Alzheimer's disease (AD) is a neurodegenerative disorder characterized by the progressive
decline of memory and cognitive function. The disease is characterized by the presence of …

The relevance of-amino-butyric acid (GABA)-ergic dysfunctions in the pathology of
Alzheimer's disease (AD) remains a matter of debate. In the present study, we characterized …

The link between histopathological hallmarks of Alzheimer's disease (AD), ie amyloid
plaques, and neurofibrillary tangles, and AD-associated cognitive impairment, has long …

Alzheimer's disease (AD) is a multifactorial, progressive, neurodegenerative disorder,
manifested by the loss of memory and cognitive abilities, behavioral disturbance and …

Alzheimer's disease (AD) is the most frequent cause of cognitive impairment in middle-aged
and older populations. There is a lack of drugs that demonstrate significant efficacy in AD, so …

Alzheimer's disease (AD) is a severe cognitive impairment considered to be the leading
cause of dementia worldwide. The pathophysiology includes extracellular accumulation of …

Alterations in the γ-aminobutyric acid (GABA) neurotransmitter and receptor systems may
contribute to vulnerability of hippocampal pyramidal neurons in Alzheimer's disease (AD) …

The increasing prevalence of Alzheimer's disease (AD) emphasizes the need for sensitive
biomarkers. Memory, a core deficit in AD, involves the interaction of distributed brain …

Background Effects of beta-amyloid accumulation on neuronal function precede the clinical
manifestation of Alzheimer's disease (AD) by years and affect distinct cognitive brain …

Alzheimer's disease (AD) is the most common neurological disease, which is associated
with gradual memory loss and correlated with synaptic hyperactivity and abnormal …